Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia

PHASE2CompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

October 29, 2010

Primary Completion Date

June 13, 2012

Study Completion Date

June 13, 2012

Conditions
Chronic Kidney DiseaseAnemia
Interventions
DRUG

Roxadustat

Oral capsule

Trial Locations (38)

Unknown

Mobile

Pine Bluff

Azusa

Chula Vista

Downey

Northridge

Paramount

Riverside

Whittier

Yuba City

Fort Lauderdale

Lauderdale Lakes

Pembroke Pines

Tampa

Augusta

Meridian

Wichita

Baton Rouge

Shreveport

Bethesda

Detroit

Lincoln

Mount Laurel

Mineola

New York

Asheville

Raleigh

Canton

Orangeburg

Knoxville

Arlington

Fort Worth

Houston

San Antonio

Fairfax

Caguas

Ponce

San Juan

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Astellas Pharma Inc

INDUSTRY

lead

FibroGen

INDUSTRY

NCT01244763 - Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia | Biotech Hunter | Biotech Hunter